Physician

Celeste Reese Willis, MD

According to 2025 Medicare claims, Celeste Willis, MD (NPI: 1104893809) practices family practice in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Russell, AL. This provider's primary affiliated billing organization is STOPWATCH URGENT CARE CENTERS LLC (NPI: 1841506458; TIN: 273255459) and primary practice location at 36867-5423.

Willis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 71 traditional Medicare patients, billed 438 HCPCS/CPT codes, and received $12,639 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,533 prescription claims across 230 beneficiaries totaling $121,506 in drug costs, led by Mounjaro (Tirzepatide). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $102,231 to $12,639. In contrast, Part D prescription costs have moved sharply higher in recent years, from $86,339 to $121,506. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$56K$113K2015 Medicare payment: $102,231 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $112,778 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $87,065 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $47,982 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $17,933 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,891 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,623 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,589 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $12,639 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155647,080$102,231
20166316,930$112,778
20175175,575$87,065
20183753,089$47,982
20191801,483$17,933
2020N/RN/RN/R
20217491$3,891
20224377$3,623
20231658$2,589
202471438$12,639

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$61K$122K2015 Drug cost: $86,339 (USD; Tot_Drug_Cst)2016 Drug cost: $96,330 (USD; Tot_Drug_Cst)2017 Drug cost: $84,068 (USD; Tot_Drug_Cst)2018 Drug cost: $55,185 (USD; Tot_Drug_Cst)2019 Drug cost: $31,782 (USD; Tot_Drug_Cst)2020 Drug cost: $11,984 (USD; Tot_Drug_Cst)2021 Drug cost: $14,446 (USD; Tot_Drug_Cst)2022 Drug cost: $56,219 (USD; Tot_Drug_Cst)2023 Drug cost: $120,126 (USD; Tot_Drug_Cst)2024 Drug cost: $121,506 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156532,231$86,339
20167632,829$96,330
20178252,986$84,068
20185511,557$55,185
2019321859$31,782
2020175332$11,984
202171253$14,446
202283722$56,219
2023721,088$120,126
20242301,533$121,506

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4568$88
87811Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)2929$41
87804Detection test by immunoassay with direct visual observation for influenza virus2448$16
96372Injection of drug or substance under skin or into muscle2336$10
J1100Injection, dexamethasone sodium phosphate, 1 mg16155$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MounjaroTirzepatide16532$18,083
EliquisApixaban19990$16,241
XareltoRivaroxaban14600$11,037
Synjardy XrEmpagliflozin/Metformin Hcl11330$6,459
Albuterol Sulfate HfaAlbuterol Sulfate551,364$1,057

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$16Novo Nordisk Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Celeste Reese Willis, MD?

Tedicare shows public-source Medicare data for Celeste Reese Willis, MD (NPI 1104893809), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Celeste Reese Willis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Celeste Reese Willis, MD?

Celeste Reese Willis, MD is linked to STOPWATCH URGENT CARE CENTERS LLC (billing NPI 1841506458) in the available physician profile data.

Does Celeste Reese Willis, MD have Open Payments data?

Celeste Reese Willis, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.